Exozymes Inc.

10/08/2025 | Press release | Distributed by Public on 10/08/2025 15:43

World Bio Markets: AI - A tool U.S. industrial biomanufacturing cannot ignore

On September 16 this year, our VP of Business Development, Zachary Karl, PhD, was part of a panel discussing the use of AI in biotech, as part of the Bio Innovations Midwest conference in Omaha, Nebraska. You can watch the entire session in the video below here.

Explore global advances in AI to speed bio innovation, drive efficiency, speed process design, and accelerate the pathway to cost parity. Our panel of experts will draw on example of AI at work across the industry from farm to end product, exploring what works and where the future lies. The session will also consider the advances that Europe and Asia are making in this field, with discussion of where America has opportunities to take the lead, and where it needs to catch up.

Hosted by:
Leo Stemp, Head of Content, Bio Innovations Midwest

Featuring:
Cees van Dok, Product Manager and UX Design Prosyn.ai, Process Design Centre
Dr Will Cao, Co-founder & CEO, Pando Bioscience
Apostolos Zournas, Postdoctoral Researcher, Agile BioFoundry - Berkeley Lab
Zachary Karl, Vice President Business Development, eXoZymes

This panel discussion was recorded at Bio Innovations Midwest on 15-16 September 2025. Find out more about the event, the only commercially focused event for the industrial biomanufacturing community in North America, here.

Credit: World Bio Market Insights TV

Exozymes Inc. published this content on October 08, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on October 08, 2025 at 21:43 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]